BLB&B Advisors’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$323K Buy
2,036
+219
+12% +$32.6K 0.01% 233
2026
Q1
$266K Sell
1,817
-16,794
-90% -$2.59M 0.01% 238
2025
Q4
$2.88M Buy
18,611
+17,076
+1,112% +$2.56M 0.12% 82
2025
Q3
$214K Sell
1,535
-1,810
-54% -$245K 0.01% 264
2025
Q2
$451K Sell
3,345
-13,163
-80% -$1.78M 0.02% 184
2025
Q1
$2.41M Buy
16,508
+6,500
+65% +$944K 0.12% 84
2024
Q4
$1.38M Buy
+10,008
New +$1.46M 0.07% 107
2015
Q4
– Sell
-5,775
Closed -$382K – 286
2015
Q3
$382K Hold
5,775
– – 0.08% 185
2015
Q2
$430K Sell
5,775
-59
-1% -$4.37K 0.09% 169
2015
Q1
$423K Buy
+5,834
New +$416K 0.09% 175

Other funds holding XLV

BLB&B Advisors's XLV Position: Q2 2026 in Review

BLB&B Advisors increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 12% in Q2 2026, buying an estimated $32.6K and bringing the position to 2,036 shares worth $323K. The position accounts for 0.01% of the portfolio, ranked #233.

BLB&B Advisors first reported a position in XLV in Q1 2015 and has held it in 10 quarters since. The position peaked at $2.88M in Q4 2025. 1,866 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • BLB&B Advisors held 2,036 shares of State Street Health Care Select Sector SPDR ETF worth $323K as of Q2 2026.
  • BLB&B Advisors bought 219 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $32.6K.
  • State Street Health Care Select Sector SPDR ETF made up 0.01% of BLB&B Advisors's portfolio in Q2 2026, its #233 holding.
  • BLB&B Advisors first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2015 and has held it in 10 quarters since.
  • BLB&B Advisors's State Street Health Care Select Sector SPDR ETF position peaked at $2.88M in Q4 2025.
  • 1,866 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on BLB&B Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.